70 related articles for article (PubMed ID: 17260474)
21. Hepatocyte growth factor counteracts transforming growth factor-beta1, through attenuation of connective tissue growth factor induction, and prevents renal fibrogenesis in 5/6 nephrectomized mice.
Inoue T; Okada H; Kobayashi T; Watanabe Y; Kanno Y; Kopp JB; Nishida T; Takigawa M; Ueno M; Nakamura T; Suzuki H
FASEB J; 2003 Feb; 17(2):268-70. PubMed ID: 12475893
[TBL] [Abstract][Full Text] [Related]
22. [Effects of simvastatin on expression of CTGF and α-SMA in renal tubulointerstitium of rats with diabetic nephropathy].
Lin FL; Shen HC; Zhu B; Lin KQ
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2010 Sep; 39(5):511-6. PubMed ID: 20936727
[TBL] [Abstract][Full Text] [Related]
23. Peroxisome proliferator-activated receptor-γ activation with angiotensin II type 1 receptor blockade is pivotal for the prevention of blood-brain barrier impairment and cognitive decline in type 2 diabetic mice.
Min LJ; Mogi M; Shudou M; Jing F; Tsukuda K; Ohshima K; Iwanami J; Horiuchi M
Hypertension; 2012 May; 59(5):1079-88. PubMed ID: 22454480
[TBL] [Abstract][Full Text] [Related]
24. Rosiglitazone ameliorates diabetic nephropathy by reducing the expression of Chemerin and ChemR23 in the kidney of streptozotocin-induced diabetic rats.
Hu W; Yu Q; Zhang J; Liu D
Inflammation; 2012 Aug; 35(4):1287-93. PubMed ID: 22350950
[TBL] [Abstract][Full Text] [Related]
25. Regulation effects of TZQ-F on adipocyte differentiation and insulin action.
Nan Xia J; Qin Zhang D; Du J; Wen J
J Ethnopharmacol; 2013 Nov; 150(2):692-9. PubMed ID: 24095827
[TBL] [Abstract][Full Text] [Related]
26. ALK-5 mediates endogenous and TGF-beta1-induced expression of connective tissue growth factor in embryonic lung.
Wu S; Peng J; Duncan MR; Kasisomayajula K; Grotendorst G; Bancalari E
Am J Respir Cell Mol Biol; 2007 May; 36(5):552-61. PubMed ID: 17197570
[TBL] [Abstract][Full Text] [Related]
27. Cilostazol ameliorates metabolic abnormalities with suppression of proinflammatory markers in a db/db mouse model of type 2 diabetes via activation of peroxisome proliferator-activated receptor gamma transcription.
Park SY; Shin HK; Lee JH; Kim CD; Lee WS; Rhim BY; Hong KW
J Pharmacol Exp Ther; 2009 May; 329(2):571-9. PubMed ID: 19221061
[TBL] [Abstract][Full Text] [Related]
28. Peroxisome proliferator-activated receptor gamma agonist improves arterial stiffness in patients with type 2 diabetes mellitus and coronary artery disease.
Yu J; Jin N; Wang G; Zhang F; Mao J; Wang X
Metabolism; 2007 Oct; 56(10):1396-401. PubMed ID: 17884451
[TBL] [Abstract][Full Text] [Related]
29. ATP synthase subunit-β down-regulation aggravates diabetic nephropathy.
Guan SS; Sheu ML; Wu CT; Chiang CK; Liu SH
Sci Rep; 2015 Oct; 5():14561. PubMed ID: 26449648
[TBL] [Abstract][Full Text] [Related]
30. Effect of catalpol on diabetic nephropathy in rats.
Dong Z; Chen CX
Phytomedicine; 2013 Aug; 20(11):1023-9. PubMed ID: 23746755
[TBL] [Abstract][Full Text] [Related]
31. [Hypoxia induces the expression and secretion of connective tissue growth factor and fibronectin by cultured renal cortical myofibroblasts].
Guo LP; Huang HC; Li JZ
Beijing Da Xue Xue Bao Yi Xue Ban; 2007 Feb; 39(1):67-71. PubMed ID: 17304331
[TBL] [Abstract][Full Text] [Related]
32. Fetal and adult fibroblasts have similar TGF-beta-mediated, Smad-dependent signaling pathways.
Colwell AS; Krummel TM; Longaker MT; Lorenz HP
Plast Reconstr Surg; 2006 Jun; 117(7):2277-83. PubMed ID: 16772929
[TBL] [Abstract][Full Text] [Related]
33. Peroxisome proliferator-activated receptor-gamma agonists induce neuroprotection following transient focal ischemia in normotensive, normoglycemic as well as hypertensive and type-2 diabetic rodents.
Tureyen K; Kapadia R; Bowen KK; Satriotomo I; Liang J; Feinstein DL; Vemuganti R
J Neurochem; 2007 Apr; 101(1):41-56. PubMed ID: 17394460
[TBL] [Abstract][Full Text] [Related]
34. Synergistic effects of pravastatin and pioglitazone in renal tubular epithelial cells induced by transforming growth factor-beta1.
Wei JL; Ma CY; Zhang YD; Li Y
Cell Biol Int; 2007 May; 31(5):451-8. PubMed ID: 17208021
[TBL] [Abstract][Full Text] [Related]
35. Effects of peroxisome proliferator-activated receptor gamma and its ligand on blood-retinal barrier in a streptozotocin-induced diabetic model.
Muranaka K; Yanagi Y; Tamaki Y; Usui T; Kubota N; Iriyama A; Terauchi Y; Kadowaki T; Araie M
Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4547-52. PubMed ID: 17003451
[TBL] [Abstract][Full Text] [Related]
36. Irbesartan ameliorates diabetic nephropathy by reducing the expression of connective tissue growth factor and alpha-smooth-muscle actin in the tubulointerstitium of diabetic rats.
Ren X; Guan G; Liu G; Liu G
Pharmacology; 2009; 83(2):80-7. PubMed ID: 19065061
[TBL] [Abstract][Full Text] [Related]
37. Connective tissue growth factor expressed in tubular epithelium plays a pivotal role in renal fibrogenesis.
Okada H; Kikuta T; Kobayashi T; Inoue T; Kanno Y; Takigawa M; Sugaya T; Kopp JB; Suzuki H
J Am Soc Nephrol; 2005 Jan; 16(1):133-43. PubMed ID: 15574513
[TBL] [Abstract][Full Text] [Related]
38. The combination of sirolimus and rosiglitazone produces a renoprotective effect on diabetic kidney disease in rats.
Flaquer M; Lloberas N; Franquesa M; Torras J; Vidal A; Rosa JL; Herrero-Fresneda I; Grinyó JM; Cruzado JM
Life Sci; 2010 Jul; 87(5-6):147-53. PubMed ID: 20600147
[TBL] [Abstract][Full Text] [Related]
39. Rosiglitazone treatment attenuates renal tissue inflammation generated by urinary tract obstruction.
Efrati S; Berman S; Chachashvili A; Cohen N; Siman-Tov Y; Averbukh Z; Weissgarten J
Nephrology (Carlton); 2009 Apr; 14(2):189-97. PubMed ID: 19143945
[TBL] [Abstract][Full Text] [Related]
40. Keratinocyte-derived vascular endothelial growth factor biosynthesis represents a pleiotropic side effect of peroxisome proliferator-activated receptor-gamma agonist troglitazone but not rosiglitazone and involves activation of p38 mitogen-activated protein kinase: implications for diabetes-impaired skin repair.
Schiefelbein D; Seitz O; Goren I; Dissmann JP; Schmidt H; Bachmann M; Sader R; Geisslinger G; Pfeilschifter J; Frank S
Mol Pharmacol; 2008 Oct; 74(4):952-63. PubMed ID: 18599600
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
